×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Impact of Pharmacovigilance on Public Health
Session Chair(s)
Sabine Straus, MD, PhD, MSc
PRAC Chair, Staff Member
Medicines Evaluation Board (MEB), Netherlands
Impact of Pharmacovigilance on Public Health
Speaker(s)
Panel Discussion
Maia Uuskula
State Agency of Medicines, Estonia
Head of the Bureau of Pharmacovigilance
Panel Discussion
Vicki Edwards, RPh
Abbvie, United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV
Panel Discussion
Inge Zomerdijk, MSc
Medicines Evaluation Board (MEB), Netherlands
Pharmacovigilance Assessor
Panel Discussion
Marco Greco, PhD
European Patients' Forum, Belgium
President
Panel Discussion
Valerie Strassmann, PhD, RPh
European Medicines Agency (EMA), Netherlands
Scientific Administrator, Data Analytics and Methods Task Force
Have an account?